Related Experiment Video
Updated: Feb 28, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Botulism mortality in the USA, 1975-2009
Kelly A Jackson1, Barbara E Mahon1, John Copeland2
1Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS D63, Atlanta, GA 30333, USA.
Botulism mortality has significantly decreased since the 1950s. However, non-infant botulism cases and older adults face higher risks, requiring targeted prevention efforts.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Botulism historically presented a high mortality rate exceeding 60% before the 1950s.
- Understanding current trends in botulism mortality is crucial for public health interventions.
Purpose of the Study:
- To analyze mortality trends and risk factors associated with botulism in the USA.
- To identify specific populations and transmission categories at higher risk for botulism-related death.
Main Methods:
- Retrospective review of confirmed botulism cases in the USA from 1975 to 2009.
- Categorization of cases by acquisition type: infant, foodborne, wound, and other/unknown.
- Multivariate logistic regression analysis for non-infant cases to identify mortality predictors.
Main Results:
- Overall botulism mortality was 3.0% (109 deaths out of 3,618 cases).
- Mortality varied significantly by age, increasing with age (0.8% in infants to 34.4% in those ≥80 years).
- Toxin type F demonstrated higher mortality (13.8%) compared to types A, B, and E.
Conclusions:
- Botulism mortality has dramatically decreased but remains a concern, particularly in non-infant cases and the elderly.
- Targeting non-infant transmission routes and focusing on older adult populations are essential for reducing botulism deaths.
- Further research into Toxin type F specific outcomes may inform treatment strategies.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
History of Microbiology
Drug Regulation
Vaccinations
Skeletal Muscle Relaxants: Therapeutic Uses
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

